VIRPAX PHARMACEUTICALS INC - COM (VRPX)

CUSIP: 928251107

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM
Total 13F shares
1,498,362
Share change
+139,734
Total reported value
$3,325,000
Price per share
$2.22
Number of holders
13
Value change
+$105,236
Number of buys
8
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 928251107?
CUSIP 928251107 identifies VRPX - VIRPAX PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VIRPAX PHARMACEUTICALS INC - COM (VRPX) as of Q1 2022

As of 31 Mar 2022, VIRPAX PHARMACEUTICALS INC - COM (VRPX) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,498,362 shares. The largest 10 holders included Kepos Capital LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, PNC Financial Services Group, Inc., Warberg Asset Management LLC, Warberg Asset Management LLC, Cambridge Investment Research Advisors, Inc., and NORTHERN TRUST CORP. This page lists 13 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.